Validate the Safety and Feasibility of the CT-guided Interventional Robot in Percutaneous Biopsy Procedure.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bin Xiong, MD, PhD
First Clinical Affiliation of Guangzhou Medical University
Principal Investigator - Nan Wang, PhD,MD
Tongji Hospital
Principal Investigator - Yu Haipeng, PhD,MD
Tianjin Medical University Cancer Institute and Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- First Clinical Affiliation of Guangzhou Medical University
Guangzhou, China
- Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
- Tongji Hospital of Huazhong University of Science and Technology
Wuhan, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Jul 2023
- Primary completion
- 3 Oct 2023
- Completion
- 24 Nov 2023
- Last update posted
- 5 Jul 2024
- Registered enrollment
- 166
- Registry id
- NCT06484764
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.